Acacia (ACRI)--a stock for the future Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Acacia (ACRI)--a stock for the future

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Lee who wrote ()	12/14/1999 6:45:00 AM
From: Paul Lee	of 1135

mo money Acacia Research Completes $21 Million Private Equity Financing PASADENA, Calif.--(BUSINESS WIRE)--December 14, 1999--Acacia Research Corporation (Nasdaq/NMS:ACRI) announced today the closing of a private equity financing of $21 million. Acacia Research President and CEO, Paul Ryan, commented, "The proceeds from this financing has increased our cash position to over $40 million and will enhance our ability to aggressively take strategic positions in emerging companies and incubate new companies in Launchpad." The offering price of $21.50 per unit was set on December 2, 1999. Each unit consists of one share of Acacia Research's common stock and one-half of a three-year callable common stock purchase warrant. Each common stock purchase warrant entitles the holder to purchase one share of Acacia Research's common stock at a price of $26.00 per share and is callable by Acacia Research once the closing bid price of the Company's common stock averages $35.00 or above for 20 consecutive trading days on the Nasdaq National Market System.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next